Syphilis is a sexually transmitted disease caused by a bacterium called treponema pallidum. Companies in the syphilis immunoassay diagnostics market are innovating in new technologies with the help of dedicated machines to automate rapid plasma regain (RPR) assays. They are improving testing capabilities for laboratories with the help of new software developments to enhance outcomes in patients.
This report contains market size and forecasts of Syphilis Immunoassay Diagnostics in Global, including the following market information:
Global Syphilis Immunoassay Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Syphilis Immunoassay Diagnostics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Nested Polymerase Chain Reaction Technique Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Syphilis Immunoassay Diagnostics include Roche, Danaher, BD, Siemens, Abbott Laboratories, Bio-Rad Laboratories, bioMérieux, DiaSorin and Fujirebio and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Syphilis Immunoassay Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Syphilis Immunoassay Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Syphilis Immunoassay Diagnostics Market Segment Percentages, by Type, 2021 (%)
Nested Polymerase Chain Reaction Technique
Multiple Polymerase Chain Reaction Technique
Global Syphilis Immunoassay Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Syphilis Immunoassay Diagnostics Market Segment Percentages, by Application, 2021 (%)
Men
Women
Global Syphilis Immunoassay Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Syphilis Immunoassay Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Syphilis Immunoassay Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Syphilis Immunoassay Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Danaher
BD
Siemens
Abbott Laboratories
Bio-Rad Laboratories
bioMérieux
DiaSorin
Fujirebio
Shenzhen New Industries Biomedical Engineering